DAVENPORT & Co LLC Decreases Holdings in Agilent Technologies, Inc. $A

DAVENPORT & Co LLC decreased its position in Agilent Technologies, Inc. (NYSE:A) by 2.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 248,166 shares of the medical research company’s stock after selling 5,068 shares during the quarter. DAVENPORT & Co LLC owned 0.09% of Agilent Technologies worth $33,946,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Board of the Pension Protection Fund purchased a new position in shares of Agilent Technologies during the fourth quarter worth approximately $27,000. Capital A Wealth Management LLC boosted its stake in shares of Agilent Technologies by 10,600.0% in the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 212 shares in the last quarter. Davis Capital Management purchased a new stake in shares of Agilent Technologies in the 3rd quarter valued at $28,000. Physician Wealth Advisors Inc. grew its holdings in shares of Agilent Technologies by 490.0% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 196 shares during the last quarter. Finally, State of Wyoming bought a new position in shares of Agilent Technologies during the 2nd quarter valued at $35,000.

Agilent Technologies Stock Up 1.9%

A stock opened at $114.16 on Wednesday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The company has a market capitalization of $32.26 billion, a price-to-earnings ratio of 25.20, a price-to-earnings-growth ratio of 2.36 and a beta of 1.31. The business’s 50 day moving average price is $125.50 and its two-hundred day moving average price is $135.25. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.81 billion. During the same quarter in the previous year, the business earned $1.31 EPS. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s payout ratio is 22.52%.

Analysts Set New Price Targets

Several research firms have weighed in on A. The Goldman Sachs Group began coverage on shares of Agilent Technologies in a research note on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price target for the company. HSBC started coverage on Agilent Technologies in a research note on Tuesday, January 20th. They set a “buy” rating and a $180.00 price objective on the stock. Evercore raised Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their target price for the company from $155.00 to $160.00 in a research note on Monday, January 5th. TD Cowen dropped their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Finally, Robert W. Baird raised their price target on Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 25th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $161.20.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.